Strategy, M&A and Restructuring
Board level advisory for pharma and nutraceutical businesses that want to grow, acquire, partner or transform with clarity.
Strategy, M&A and Restructuring by Zanax Healthcare
The pharmaceutical landscape is shifting quickly with pricing pressure, regulatory change and consolidation. Growth now depends on sharp strategy and well executed transactions.
Our advisory team combines industry operating experience with financial and deal expertise. We help promoters, investors and management teams make confident decisions on markets, portfolios, acquisitions and turnarounds.
What We Deliver
Market Entry Strategy
Opportunity mapping, regulatory pathway and go to market plans.
Portfolio Planning
Product selection, lifecycle planning and pipeline prioritisation.
Target Identification
Screening and outreach to acquisition or partnership targets.
Due Diligence
Commercial, technical and regulatory due diligence.
Deal Support
Valuation inputs, negotiation support and transaction structuring.
Restructuring
Operational turnaround, cost optimisation and post merger integration.
Our Process
Diagnose
Understand goals, current position and market context.
Strategise
Build options, scenarios and a clear recommendation.
Execute
Run the transaction or transformation programme.
Integrate
Track value capture and embed changes for the long term.
Why Clients Choose Us
- Deep pharma operating and regulatory knowledge
- Independent, conflict free advice
- Access to a network of investors and promoters
- Confidential handling of sensitive mandates
- Outcome focused engagement models
Frequently Asked Questions
Do you work with investors or only operating companies?
Both. We advise promoters, private equity funds, family offices and strategic buyers evaluating opportunities in pharma and nutraceuticals.
Can you help us find a manufacturing partner or acquisition target?
Yes. We screen, shortlist and approach suitable partners and targets based on your criteria, while keeping your identity confidential.
How are advisory engagements structured?
Engagements can be retainer based, project based or success fee linked, depending on the scope and nature of the mandate.
Do you provide business valuations?
We provide valuation inputs and industry benchmarks as part of deal support and work alongside registered valuers and financial advisors where formal valuations are required.
Can you help a struggling pharma unit turn around?
Yes. We assess operations, portfolio, compliance and costs, then build and support a practical turnaround plan with measurable milestones.
Related Services
Global Pharma Trading
Reliable sourcing and export of finished formulations, APIs and nutraceuticals to regulated and emerging markets worldwide.
Explore ServiceTurnkey Pharma Projects
Concept-to-commissioning support for pharmaceutical and nutraceutical plants designed to WHO-GMP, EU-GMP and US FDA standards.
Explore ServiceR&D and Product Development
Formulation development, analytical services, stability studies and technology transfer for pharmaceuticals and nutraceuticals.
Explore ServiceReady to Discuss Your Strategy, M&A and Restructuring Requirement?
Share your requirement and our specialists will get back within one business day with a clear plan, timeline and quote.